AAP
LLY icon

Aristotle Atlantic Partners’s Eli Lilly LLY Stock Holding History

Aristotle Atlantic Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.4M Sell
27,877
-503
-2% -$514K 1.39% 23
2026
Q1 		$26.1M Sell
28,380
-214
-0.7% -$217K 1.22% 28
2025
Q4 		$30.7M Sell
28,594
-39,396
-58% -$37.7M 1.41% 20
2025
Q3 		$51.9M Buy
67,990
+5,500
+9% +$4.09M 1.5% 18
2025
Q2 		$48.7M Buy
62,490
+19,294
+45% +$15M 1.48% 17
2025
Q1 		$35.7M Buy
43,196
+2,019
+5% +$1.68M 1.2% 25
2024
Q4 		$31.8M Buy
41,177
+15,608
+61% +$12.9M 1% 24
2024
Q3 		$22.7M Buy
25,569
+2,792
+12% +$2.51M 0.7% 38
2024
Q2 		$20.6M Buy
22,777
+14,503
+175% +$11.6M 0.67% 43
2024
Q1 		$6.44M Buy
8,274
+2,165
+35% +$1.54M 0.21% 69
2023
Q4 		$3.56M Buy
6,109
+5,609
+1,122% +$3.27M 0.13% 72
2023
Q3 		$269K Hold
500
– – 0.01% 94
2023
Q2 		$234K Buy
+500
New +$210K 0.01% 99

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aristotle Atlantic Partners's LLY Position: Q2 2026 in Review

Aristotle Atlantic Partners reduced its Eli Lilly (LLY) stake by 1.8% in Q2 2026, selling an estimated $514K and leaving 27,877 shares worth $33.4M. The position accounts for 1.39% of the portfolio, ranked #23.

Aristotle Atlantic Partners first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. The position peaked at $51.9M in Q3 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Aristotle Atlantic Partners held 27,877 shares of Eli Lilly worth $33.4M as of Q2 2026.
  • Aristotle Atlantic Partners sold 503 Eli Lilly shares in Q2 2026, an estimated $514K.
  • Eli Lilly made up 1.39% of Aristotle Atlantic Partners's portfolio in Q2 2026, its #23 holding.
  • Aristotle Atlantic Partners first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • Aristotle Atlantic Partners's Eli Lilly position peaked at $51.9M in Q3 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Aristotle Atlantic Partners's 13F filing for Q2 2026, filed 14 Aug 2026.